« Previous
Next »
American Journal of Cardiology
Volume 103, Issue 5
, Pages 690-694
, 1 March 2009
Comparison of Time Course of Response to Cardiac Resynchronization Therapy in Patients With Ischemic Versus Nonischemic Cardiomyopathy
References
- ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(suppl):e154–e235
- Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108
- . Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure. J Cardiovasc Electrophysiol. 2004;15:544–549
- Predictors of response to cardiac resynchronization therapy (PROSPECT)—study design. Am Heart J. 2005;149:600–605
- . Usefulness of atrioventricular delay optimization using Doppler assessment of mitral inflow in patients undergoing cardiac resynchronization therapy. Am J Cardiol. 2006;98:780–785
- Cardiac resynchronization therapy: part 1—issues before device implantation. J Am Coll Cardiol. 2005;46:2153–2167
- . Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97:260–263
- . Echocardiographic quantification of left ventricular asynchrony predicts an acute hemodynamic benefit of cardiac resynchronization therapy. J Am Coll Cardiol. 2002;40:536–545
- . Utility of echocardiographic radial strain imaging to quantify left ventricular dyssynchrony and predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2005;96:112–116
- . Usefulness of echocardiographic tissue synchronization imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2004;93:1178–1181
- . Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 1999;99:1567–1573
- . Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2008;19:392–399
- . Usefulness of triplane tissue Doppler imaging to predict acute response to cardiac resynchronization therapy. Am J Cardiol. 2007;100:476–482
- . Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112:1580–1586
- . Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulation in Cardiomyopathies) trial. Eur Heart J. 2003;24:430–441
- . Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE). Circulation. 2006;113:266–272
- . Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy. Europace. 2007;9:1031–1037
- . Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony. J Am Coll Cardiol. 2006;48:1953–1960
- . Effect of total scar burden on contrast-enhanced magnetic resonance imaging on response to cardiac resynchronization therapy. Am J Cardiol. 2007;99:657–660
Dr. Bax received grants from Medtronic, Minneapolis, Minnesota, Boston Scientific, Natick, Massachusetts, BMS Medical Imaging, Bruxelles, Belgium, St. Jude Medical, St. Paul, Minnesota, and General Electric Healthcare, Horten, Norway. Dr. Schalij received grants from Biotronik, Berlin, Germany, Medtronic, and Boston Scientific. Dr. Marsan and Dr. Delgado are supported by a research grant from the European Society of Cardiology.
PII: S0002-9149(08)01989-9
doi: 10.1016/j.amjcard.2008.11.008
© 2009 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 103, Issue 5
, Pages 690-694
, 1 March 2009
